METTL3 and metabolic dysfunction-associated steatotic liver disease: When METTL3 is knocked down, DDIT4 reduces the level of lipid accumulation and the activity of inflammation in hepatocytes of the NAFLD patients by the signaling pathway of the mechanistic target of rapamycin complex 1 (mTORC1) and NF-κB (79).